Fox Chase Cancer Center

Philadelphia (United States us)
Oncology

Bibliometric indicators

Evolution over the last years of activity

Showing the period - Sept. 2024

20,657
Activity
3%

Total documents

2.83
Impact
3%

Normalized Impact

4,644
Excellence
3%

Highly Cited Papers (Top 10%)

74.6
Leadership
3%

Leadership (%)

25.0
Mobility & Collaboration
3%

International Collaboration (%)

831
Excellence
3%

Outstanding papers (Top 1%)

14.2
Leadership
3%

Women Leading (%)

2.7
Leadership
3%

Women Leading International (%)

45.7
Open Access
3%

Open Access (%)

Main Research Fields (top 9 by publications)

Indicators:

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Human Resources

Historical perspective

From to Sept. 2024

Current resources

Quick filters

Career Stage
Occasional Junior Researcher Senior Leading
Performance
Standard Good Excellent Outstanding
Gender
Male Female
Reset
0

Personnel

0.0

Papers / Personnel

0

Leading women (%)

0
0

Gender (%)

0

Papers / Permanent researchers

0

Papers / Leading researchers

Career stage

Performance

Years of Activity

ONE Index (distribution)

ONE Index by Main Research Fields

ONE Index vs. Years of Activity

Main authors

ID Name Gender Discipline Career Stage ONE Index Years Activity NDocs RCI HCP Leader Collab.
1 Borghaei, Hossein male Oncology Senior researcher 885 25 464 5.38 91 25.7% 36.9%
2 Plimack, Elizabeth female Surgery Senior researcher 885 21 476 7.71 144 22.7% 34.7%
3 Denlinger, Crystal female Oncology Senior researcher 881 21 216 4.06 44 35.2% 22.7%
4 Testa, Joseph male Molecular Biology, Pulmonary and Respiratory Medicine Leading researcher 875 49 481 2.78 135 51.1% 13.9%
5 von Mehren, Margaret female Pulmonary and Respiratory Medicine Leading researcher 871 37 390 5.32 114 31.0% 36.9%
6 Grivennikov, Sergei male Immunology Senior researcher 869 23 118 6.56 48 30.5% 50.9%
7 Richard I. Fischer Pathology and Forensic Medicine Leading researcher 861 188 466 6.22 141 42.3% 16.7%
8 Hall, Michael male Oncology Leading researcher 854 77 365 2.42 66 46.3% 23.0%
9 Farma, Jeffrey male Oncology Senior researcher 851 22 204 2.82 35 41.2% 17.2%
10 Dunbrack, Roland male Molecular Biology Leading researcher 849 39 309 4.64 80 56.6% 12.9%
11 Daly, Mary female Genetics Leading researcher 847 55 302 2.49 67 36.4% 30.1%
12 Geynisman, Daniel male Surgery Senior researcher 843 20 265 2.11 51 43.4% 14.7%
13 Konski, Andre male Pulmonary and Respiratory Medicine Leading researcher 836 39 342 2.18 58 46.2% 11.4%
14 W. Freeman Mason Epidemiology Leading researcher 834 53 152 3.53 51 64.5% 21.7%
15 Ridge, John male Otorhinolaryngology, Surgery Leading researcher 833 175 334 4.95 81 21.9% 17.4%
16 Horwitz, Eric male Pulmonary and Respiratory Medicine Leading researcher 831 40 459 3.03 106 26.4% 16.3%
17 Garret T. Hanks Pulmonary and Respiratory Medicine Leading researcher 830 64 578 2.10 118 67.3% 7.3%
18 Flieder, Douglas male Pulmonary and Respiratory Medicine Senior researcher 828 29 141 10.47 52 36.2% 24.8%
19 Baruch Samuel Blumberg Epidemiology Leading researcher 828 71 363 2.53 78 79.3% 19.6%
20 Goldstein, Lori female Oncology Leading researcher 827 67 253 5.19 78 36.4% 17.0%
21 Roder, Heinrich male Researcher 826 52 293 1.82 71 46.8% 24.9%
22 Meropol, Neal male Oncology Leading researcher 822 66 412 3.37 105 36.7% 10.0%
23 Klein-Szanto, Andres male Molecular Biology Leading researcher 822 55 554 1.96 132 27.6% 17.5%
24 Golemis, Erica female Molecular Biology Leading researcher 819 38 373 1.68 70 54.7% 23.1%
25 Burton Larry Eisenberg Pulmonary and Respiratory Medicine Leading researcher 817 66 221 3.32 42 39.8% 13.6%
885
One Index
Borghaei, Hossein PhD   0000-0002-2577-4454 464 docs (2000 - 2024)  
EGFR Mutations , Clinical endpoint , Carboplatin , Pemetrexed , Non-Small Cell Lung Cancer
885
One Index
Plimack, Elizabeth PhD   0000-0002-7618-0744 476 docs (2004 - 2024)  
Urothelial Carcinoma , Neoadjuvant Therapy , Atezolizumab , Metastatic Urothelial Carcinoma , Metastatic Bladder Cancer
881
One Index
Denlinger, Crystal PhD   0000-0002-5663-7751 216 docs (2004 - 2024)  
Cancer Survivorship , Clinical endpoint , Metastatic Colorectal Cancer , Tolerability , Ramucirumab
875
One Index
Testa, Joseph PhD   0000-0003-1301-5175 481 docs (1976 - 2024)  
BAP1 , Malignant Pleural Mesothelioma , Asbestos exposure , Tumor Suppressor Genes , AKT2
871
One Index
von Mehren, Margaret PhD   0000-0001-6158-890X 390 docs (1988 - 2024)  
PDGFRA , Stromal tumor , Trabectedin , Clinical endpoint , Soft Tissue Sarcoma
869
One Index
Grivennikov, Sergei PhD   0000-0003-2987-0555 118 docs (2002 - 2024)  
Cancer , Tumor Microenvironment , Inflammation , cytokine signaling , Proinflammatory cytokine
861
One Index
Richard I. Fischer PhD 466 docs (1837 - 2023)  
Follicular lymphoma , Mantle Cell Lymphoma , Regimen , International Prognostic Index , B-Cell Receptor Signaling
854
One Index
Hall, Michael PhD   0000-0003-4515-3409 365 docs (1948 - 2024)  
Cancer Risk , Genetic Testing , cancer susceptibility , Cancer Genomics , Intratumor Heterogeneity
851
One Index
Farma, Jeffrey PhD   0000-0003-2966-9704 204 docs (2003 - 2024)  
Melanoma , Surgical oncology , Soft Tissue Sarcoma , Neoadjuvant Therapy , Merkel Cell Carcinoma
849
One Index
Dunbrack, Roland PhD   0000-0001-7674-6667 309 docs (1986 - 2024)  
Protein Data Bank , Proteins , Protein Stability , Intratumor Heterogeneity , Tumor Evolution
847
One Index
Daly, Mary PhD   0000-0002-7490-6038 302 docs (1970 - 2024)  
Breast Cancer , cancer susceptibility , Cancer Risk , Genetic Testing , Healthy Eating Index
843
One Index
Geynisman, Daniel PhD   0000-0002-1423-5295 265 docs (2005 - 2024)  
Urothelial Carcinoma , Atezolizumab , Metastatic Urothelial Carcinoma , Neoadjuvant Therapy , Gut Microbiota
836
One Index
Konski, Andre PhD   0000-0002-6936-7682 342 docs (1986 - 2024)  
Radiotherapy , Chemoradiotherapy , Intensity-Modulated Radiotherapy , Clinical endpoint , Cancer Treatment Expenses
834
One Index
W. Freeman Mason PhD 152 docs (1972 - 2021)  
Woodchuck hepatitis virus , cccDNA , HBV Infection , Rous sarcoma virus , Hepatitis B Virus
833
One Index
Ridge, John PhD   0000-0002-5527-3546 334 docs (1850 - 2024)  
Radiotherapy , Squamous-Cell Carcinoma , Neck dissection , Biomarker Analysis , Tumor Heterogeneity
831
One Index
Horwitz, Eric PhD   0000-0003-2187-317X 459 docs (1985 - 2024)  
Prostate Cancer , Metastatic Prostate Cancer , External beam radiotherapy , Intensity-Modulated Radiotherapy , Clinical endpoint
830
One Index
Garret T. Hanks PhD 578 docs (1961 - 2024)  
Prostate Cancer , Metastatic Prostate Cancer , Radiotherapy , Radiation oncology , External beam radiotherapy
828
One Index
Flieder, Douglas PhD   0000-0002-7422-4213 141 docs (1996 - 2025)  
Lung Cancer , Tumor Staging , Lung Nodules , Non-Small Cell Lung Cancer , Autophagy
828
One Index
Baruch Samuel Blumberg PhD 363 docs (1954 - 2020)  
Hepatitis B , Hepatitis B Virus , HBV Infection , Chronic Hepatitis B , Hepatocellular Carcinoma
827
One Index
Goldstein, Lori PhD   0000-0002-6542-3421 253 docs (1958 - 2024)  
Breast Cancer , Metastatic Breast Cancer , Triple-negative breast cancer , Neoadjuvant Therapy , Clinical endpoint
826
One Index
Roder, Heinrich PhD   0000-0003-1860-2491 293 docs (1973 - 2023)  
Folding (DSP implementation) , Biomarker Analysis , Lattice (music) , Biomarkers for Immunotherapy , Microsecond
822
One Index
Meropol, Neal PhD   0000-0001-6353-7364 412 docs (1959 - 2024)  
Metastatic Colorectal Cancer , Cancer Treatment Expenses , Patient Participation , Research Participation , Clinical endpoint
822
One Index
Klein-Szanto, Andres PhD   0000-0002-5533-9402 554 docs (1970 - 2024)  
BAP1 , Cancer Therapy , Tumor Microenvironment , Epidermis (zoology) , Cancer
819
One Index
Golemis, Erica PhD   0000-0003-3618-3673 373 docs (1987 - 2024)  
Cancer Therapy , EGFR Mutations , Table (database) , Protein-Protein Interaction Networks , Tumor Microenvironment
817
One Index
Burton Larry Eisenberg PhD 221 docs (1959 - 2024)  
Stromal tumor , Soft Tissue Sarcoma , Imatinib Mesylate , Imatinib mesylate , Treatment